A Study of Duvelisib in Combination With Rituximab and Bendamustine vs Placebo in Combination With Rituximab and Bendamustine in Subjects With Previously-Treated Indolent Non-Hodgkin Lymphoma (BRAVURA)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This study will evaluate the efficacy and safety of duvelisib in combination with bendamustine and rituximab (DBR) vs placebo in combination with bendamustine and rituximab (PBR) in subjects with previously-treated indolent non-Hodgkin lymphoma (iNHL).
Epistemonikos ID: 94464ef59c1f2f2b1e5c459ce9d21bc79ddec767
First added on: May 12, 2024